Latest news

Becker’s Healthcare | January 12, 2023

EXCERPT: Mayo Clinic and Kaiser Permanente were part of a $110 million funding round for Medically Home in January 2022 after becoming joint strategic investors the previous May.

Post Bulletin | January 6, 2023

EXCERPT:  Mayo Clinic Chief Business Development Officer Jim Rogers spoke to highlight Mayo Clinic’s innovation, citing the launch or involvement with 32 startup companies in 2022 as well as that Mayo inventors have been issued 232 patents. 

Fierce Biotech | December 16, 2022

EXCERPT:  Originally launched in 2021 as a joint venture between nference and the Mayo Clinic, Anumana will now work with Pfizer on a multiyear research project.

Healthcare Changemakers Podcast | November 30, 2022

Mayo Clinic News Network | November 29, 2022

Additional Sources: YouTubeApple PodcastsSpotify

Post Bulletin | October 20, 2022

EXCERPT:  “Today’s Investment in Healing Conference brought together key collaborators who are playing a pivotal role in the creation of a dynamic platform ecosystem,” wrote Mayo Clinic President and CEO Dr. Gianrico Farrugia.

BioSpace | September 20, 2022

EXCERPT:  MoatBio holds an exclusive patent license from Mayo Clinic for the novel second generation single-cycle adenovirus vaccine platform (SC-AdVax) to develop intranasal and oral vaccines that can elicit and boost both mucosal and systemic immunity for the treatment of infectious diseases, like COVID-19. 

Mass Device | August 1, 2022

EXCERPT:  Mayo Clinic participated, making the Israel-based firm a Mayo Clinic portfolio company.

Med City News | July 15, 2022

EXCERPT:  Anumana was formed by Mayo Clinic and nference, a company that uses unstructured electronic medical records data from medical centers to develop new diagnostics and treatments.

Mass Devices | May 24, 2022

EXCERPT:  The algorithm is Anumana’s second to receive a breakthrough nod, with its low ejection fraction algorithm (developed by Mayo Clinic and licensed by Anumana) garnering approval in 2019, plus FDA emergency use authorization (EUA) for COVID-19 in 2020.

Star Tribune | May 17, 2022

EXCERPT: The company, an outgrowth of Mayo Clinic, recently raised more money from investors as it seeks new ways to treat cancer

Mayo Clinic News Network | May 2, 2022

EXCERPT: Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump.

Business Wire | March 16, 2022

EXCERPT: Pramana’s first commercial agreement with Mayo Clinic is a multi-year collaboration that includes an industry-leading initiative to digitize 5 million slides – one of the largest digitization efforts in the world to date, at an unprecedented rate.

Star Tribune | February 7, 2022

EXCERPT: The company [Medical21] is collaborating with Mayo Clinic, which owns an equity stake in the company. Juan Crestanello, a cardiovascular surgeon at Mayo, said he and his colleagues have seen some of Medical 21’s work. “The results, so far, have been very encouraging,” Crestanello said. 

PR Newswire | January 19, 2022

EXCERPT: Pathogenomix, Inc. collaborated with Mayo Clinic on the development of the techniques and data which supported the application for this FDA Breakthrough Device Designation. 

Star Tribune | December 23, 2021

EXCERPT: “We anticipate that we’ll have relationship with pretty much every company in Two Discovery Square,” said Dr. Clark Otley, medical director of the Department of Business Development at Mayo Clinic. 

Medical Design & Outsourcing | February 3, 2021